Clinical Trials

Phase 3 Active not recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT00070564 2025-07-31

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

3,294 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00003782 2024-03-21

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

5,351 enrolled 8 charts

Breast Neoplasms

NCT00003519 2023-06-15

Combination Chemotherapy in Treating Women With Breast Cancer

2,778 enrolled

Breast Neoplasms

NCT00004125 2023-06-15

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Breast Neoplasms

NCT03412643 2023-03-06

FB-12

Phase 2 Unknown

64 enrolled

Breast Neoplasms

NCT00087178 2022-08-11

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

2,722 enrolled 14 charts

Breast Neoplasms

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

1,613 enrolled

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase 3 Unknown

1,871 enrolled

Breast Neoplasms

NCT01008150 2021-10-25

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

141 enrolled 16 charts

Breast Neoplasms

NCT01705691 2021-10-06

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

50 enrolled 14 charts

Breast Neoplasms

NCT00004067 2021-04-29

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

2,130 enrolled

Breast Neoplasms

NCT00365417 2021-04-13

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

45 enrolled 15 charts

Breast Neoplasms

NCT00014222 2020-10-05

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

2,104 enrolled 11 charts

Breast Neoplasms

NCT00002542 2020-04-01

Tamoxifen in Treating Women With High-Risk Breast Cancer

672 enrolled

Breast Neoplasms

NCT01099436 2020-01-21

NEO-ZOTAC

250 enrolled

Breast Neoplasms

NCT01935492 2020-01-18

Stop&Go

420 enrolled

Breast Neoplasms

NCT00093795 2018-01-11

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

4,894 enrolled 12 charts

Breast Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast Neoplasms

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

215 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00486668 2016-06-06

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

Phase 3 Unknown

529 enrolled

Invasive Breast Cancer

NCT01495884 2015-10-26

The Myocet/Lapatinib Study. ICORG 10-03, V5

Phase 1/2 Terminated

11 enrolled

Her2 Positive Metastatic Breast Cancer

NCT00002529 2013-04-04

12-93

452 enrolled

Breast Neoplasms

NCT00002784 2013-04-04

15-95

344 enrolled

Breast Neoplasms

NCT00002772 2013-01-24

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 3 Terminated

602 enrolled

Breast Neoplasms

NCT00016406 2013-01-24

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

399 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00929591 2013-01-24

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

1,558 enrolled

Breast Neoplasms

NCT00003352 2012-12-11

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

89 enrolled

Breast Neoplasms

NCT00002707 2010-02-03

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

2,411 enrolled